Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia in CKD Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04959578
What this trial is testing

Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease

Who this might be right for
Anemia of Chronic Kidney Disease
Rufaida Mazahir 50
Large-scale testing (Phase 3)Study completedNCT00717821
What this trial is testing

Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.

Who this might be right for
Anemia
Hoffmann-La Roche 421
Large-scale testing (Phase 3)Study completedNCT01473420
What this trial is testing

Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Who this might be right for
Chronic Renal FailureChronic Kidney Disease
Pfizer 320
Large-scale testing (Phase 3)Study completedNCT03431623
What this trial is testing

CKD-11101 Phase 3 SC Study

Who this might be right for
Anemia of Chronic Kidney Disease
Chong Kun Dang Pharmaceutical 248
Large-scale testing (Phase 3)Study completedNCT01576341
What this trial is testing

HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease
Sandoz 417
Post-approval studies (Phase 4)UnknownNCT02648126
What this trial is testing

Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa

Who this might be right for
Red-Cell Aplasia, PureRenal Insufficiency, Chronic
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 531
Post-approval studies (Phase 4)Study completedNCT02817555
What this trial is testing

Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients

Who this might be right for
AnemiaChronic Kidney Disease
Andrea L Woodland 50
Not applicableLooking for participantsNCT07741279
What this trial is testing

Real-World Study of Enarodustat for Anemia in Non-Dialysis CKD Patients

Who this might be right for
Anemia of Chronic Kidney DiseaseCKDNon-dialysis Chronic Kidney Disease
Huashan Hospital 90
Post-approval studies (Phase 4)Study completedNCT02787824
What this trial is testing

Periodic Versus Continuous IV Iron Supplementation in HD Patients

Who this might be right for
Anemia of Chronic Kidney Disease
Papageorgiou General Hospital 27
Large-scale testing (Phase 3)Study completedNCT04027517
What this trial is testing

Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.

Who this might be right for
Anemia of Chronic Kidney Disease
JW Pharmaceutical 172
Post-approval studies (Phase 4)Study completedNCT06115421
What this trial is testing

Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients

Who this might be right for
Anemia in Dialysis-dependent CKD Patients
Alexandria University 72
Not applicableNot Yet RecruitingNCT07676526
What this trial is testing

Association Between Chronic Kidney Disease Stage and Circulating FGF23 Cleavage Intensity in Patients With Chronic Kidney Disease

Who this might be right for
CKD - Chronic Kidney Disease
Centre Hospitalier Universitaire de Saint Etienne 80
Large-scale testing (Phase 3)Ended earlyNCT00364845
What this trial is testing

STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients

Who this might be right for
AnemiaChronic Kidney Disease
Amgen 51
Large-scale testing (Phase 3)Study completedNCT02278341
What this trial is testing

Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis

Who this might be right for
AnemiaEnd Stage Renal Disease (ESRD)
Astellas Pharma Europe B.V. 838
Not applicableLooking for participantsNCT04330729
What this trial is testing

The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp

Who this might be right for
Erythropoietin Adverse Reaction
Zealand University Hospital 60
Large-scale testing (Phase 3)Study completedNCT00559273
What this trial is testing

Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis

Who this might be right for
Renal Anemia, Chronic
Hoffmann-La Roche 307
Post-approval studies (Phase 4)Study completedNCT00224042
What this trial is testing

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents

Who this might be right for
Anemia, Iron-DeficiencyKidney Failure, Chronic
Watson Pharmaceuticals 52
Testing effectiveness (Phase 2)Study completedNCT00228449
What this trial is testing

Peginesatide for Anemia in Chronic Hemodialysis Patients

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 165
Large-scale testing (Phase 3)Study completedNCT02174627
What this trial is testing

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

Who this might be right for
Anemia
AstraZeneca 2,781
Testing effectiveness (Phase 2)Study completedNCT05035641
What this trial is testing

AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

Who this might be right for
Renal Anemia
Kind Pharmaceuticals LLC 113
Next Page